How multidisciplinary care, cyst surveillance, advanced endoscopy, robotic surgery and targeted therapies are reshaping the outlook for pancreatitis and pancreatic cancer.
Video Highlights
Acute pancreatitis is rising, with gallstones, obesity, medications and smoking remaining important clinical considerations.
Evaluation of pancreatitis requires attention to overlooked causes, including medication-related, genetic and malignancy-associated etiologies.
Pancreatitis management is shifting from aggressive fluid resuscitation to early, tailored resuscitation with careful monitoring.
Pancreatic cyst surveillance is presented as a potential pathway toward earlier pancreatic cancer detection.
Emerging technologies and therapies may reshape both the diagnosis and treatment of pancreatic cancer.
This roundtable discussion explores evolving approaches to identifying and treating pancreatic diseases, including shifts in acute pancreatitis management, improved recognition of underlying causes and the importance of multidisciplinary care. The conversation highlights the growing role of pancreatic cyst surveillance programs in identifying patients at risk for pancreatic cancer earlier in the disease course. The panelists also examine advances in endoscopic and surgical techniques, molecular diagnostics and AI-driven tools that may improve diagnosis and patient selection. Looking ahead, emerging targeted therapies and precision medicine strategies offer new opportunities to improve outcomes for patients with pancreatic cancer.